Horizon Therapeutics (HZNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -40,612 | -22,171 | -87,794 | -63,461 | -46,508 |
| Depreciation Amortization | 5,684 | 2,832 | 8,278 | 3,648 | 2,140 |
| Accounts receivable | -3,880 | -4,300 | -1,087 | -3,600 | 1,751 |
| Accounts payable and accrued liabilities | -348 | -1,026 | -2,209 | -1,314 | -255 |
| Other Working Capital | -2,816 | -6,197 | -3,980 | -7,397 | 2,015 |
| Other Operating Activity | 8,304 | 8,093 | 10,151 | 12,651 | 4,210 |
| Operating Cash Flow | $-33,668 | $-22,769 | $-76,641 | $-59,473 | $-36,647 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -345 | -225 | -1,336 | -1,012 | -1,043 |
| Other Investing Activity | 0 | 0 | -50 | -50 | 0 |
| Investing Cash Flow | $-345 | $-225 | $-1,386 | $-1,062 | $-1,043 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 55,578 | 55,578 | 55,578 |
| Debt Repayment | -3,978 | N/A | -19,788 | -19,780 | -19,814 |
| Common Stock Issued | 3,243 | N/A | 128,518 | 128,388 | 47,622 |
| Financing Cash Flow | $-735 | $N/A | $164,308 | $164,186 | $83,386 |
| Exchange Rate Effect | 1 | -17 | -160 | -291 | -202 |
| Beginning Cash Position | 104,087 | 104,087 | 17,966 | 17,966 | 17,966 |
| End Cash Position | 69,340 | 81,076 | 104,087 | 121,326 | 63,460 |
| Net Cash Flow | $-34,747 | $-23,011 | $86,121 | $103,360 | $45,494 |
| Free Cash Flow | |||||
| Operating Cash Flow | -33,668 | -22,769 | -76,641 | -59,473 | -36,647 |
| Capital Expenditure | -345 | -225 | -1,336 | -1,012 | -1,043 |
| Free Cash Flow | -34,013 | -22,994 | -77,977 | -60,485 | -37,690 |